Modulatory effect of 8-iso-PGE2 on platelets

General Pharmacology

Volumn 28, Issue 2, 1997, Pages 317-321

  Kobzar, Gennadi ^a   Mardla, Vilja ^a   Järving, Ivar ^a   Samel, Nigulas ^a   Lõhmus, Madis ^a  

^a TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

Author keywords

8 iso PGE2; ADP; adrenaline; human platelets; indomethacin; isoprostane; PAF; platelet aggregation; rabbit platelets

Indexed keywords

8 ISOPROSTAGLANDIN E2; ADENOSINE DIPHOSPHATE; ADRENALIN; INDOMETACIN; PROSTAGLANDIN DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RABBIT; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

ADENOSINE DIPHOSPHATE; ANIMALS; BLOOD PLATELETS; DINOPROSTONE; EPINEPHRINE; HUMANS; ISOPROSTANES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RABBITS;

EID: 0031021433     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00224-8     Document Type: Article

References (22)

1. Agarwal K. C., Clarke E., Rounds S., Parks Jr. R. E. and Huzoor-Akbar (1994) Platelet-activating factor (PAF)-induced platelet aggregation. Modulation by plasma adenosine and methylxanthines. Biochem. Pharmacol. 48, 1909-1916.
2. 2a in rabbit lung in situ. Am. J. Physiol. 263, H660-H663.
3. Bertagnolli M. E. and Beckerle M. C. (1994) Regulated membrane-cytoskeleton linkages in platelets. Ann. N.Y. Acad. Sci. 714, 88-98.
4. Born G. V. R. (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194, 927-929.
5. ++ concentrations. Thromb. Res. 75, 233-242.
6. 2a in vivo is not affected by cyclooxygenase inhibition. In: Advances in Prostaglandin, Thromboxane, and Leukotriene Research, vol. 23. Edited by Samuelsson B. et al., pp. 233-236. Raven Press, New York.
7. Cathill M., Mistry R. and Barnett D. B. (1992) The human platelet fibrinogen receptor: clinical and therapeutic significance. Br. J. Clin. Pharmacol. 33, 2-9.
8. Ekholm J., Tatsumi Y., Nouchi T., and Hanahan D. J. (1992) The human platelet as a reproducible and sensitive cell for the detection and assay of platelet-activating factor. Anal. Biochem. 204, 79-84.
9. 2-isoprostane receptors on rat vascular smooth muscle cells. Am. J. Physiol. 264, C1619-1624.
10. 2-isoprostane. Biochem. Biophys. Res. Com. 195, 507-515.
11. Kinlough-Rathbone R. L., Packham M. A. and Mustard J. F. (1983) Platelet aggregation. In: Measurement of Platelet Function. Edited by Harker L. A. and Zimmerman T. S., pp. 64-99. Churchill Livingstone, Edinburgh.
12. Kobzar G., Mardla V., Järving I., Lõhmus M., Vahemets A., Samel N. and Lille Ü. (1993) Comparison of the inhibitory effect of E-prostaglandins in human and rabbit platelet-rich plasma and washed platelets. Comp. Biochem. Physiol. 106C, 489-494.
13. 2 on platelets and smooth muscles. Pharmacol. Toxicol. 76 (suppl. III), 34.
14. Lõhmus M., Vahemets A., Järving I., Samel N., Lille Ü. and Pehk T. (1990) Preparative separation of natural prostaglandin E. Prep. Chromat. 1, 279-300.
15. 2 on the platelet thromboxane/endoperoxide receptor in humans and rats: additional evidence for the existence of a unique isoprostane receptor. Prostaglandins 48, 247-256.
16. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA 87, 9383-9387.
17. 2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J. Clin. Invest. 90, 2502-2507.
18. 2a, a potent agonist of the vascular thromboxane/ endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins 44, 155-163.
19. Morrow J. D., Minton T. A., Mukudan C. R., Campbell M. D., Zackert W. E., Daniel V. C., Badr K. F., Blair I. A. and Roberts L. J. II. (1994) Free radical-induced generation of isoprostanes in vivo. Evidence for the formulation of D-ring and E-ring isoprostanes. J. Biol. Chem. 269, 4317-4326.
20. 2a by human platelets. In: Advances in Prostaglandin, Thromboxane and Leukotriene Research, vol. 23. Edited by Samuelsson B. et al., pp. 229-231. Raven Press, New York.
21. 2-receptors. J. Clin. Invest. 90, 136-141.
22. Vargas J. R., Radomski M. and Moncada S. (1982) The use of prostacyclin in the separation of plasma and washing of human platelets. Prostaglandins 23, 923-945.